Mobile Gamma Cameras Market Size & Share by, End User (Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, Specialized Clinics); Product Type; Indications - Global Industry Analysis, Trends, Supply Chain, Pricing Analysis, Trade, Leading Companies, Regional Outlook, and Forecast 2026-2036

Mobile Gamma Cameras Market: Market Overview & Supply Chain

Adoption of the mobile gamma cameras market is increasing as healthcare providers seek flexible nuclear medicine imaging capabilities that can complement fixed diagnostic infrastructure. Mobile systems can support imaging closer to patients, improve equipment utilization, and serve facilities where dedicated nuclear medicine rooms are constrained. The broader clinical relevance of nuclear medicine is substantial: the World Health Organization reports that more than 40 million nuclear medicine procedures are performed worldwide annually, demonstrating the established role of nuclear medicine in diagnostic and therapeutic healthcare. The technology is also relevant to cancer diagnosis, treatment planning, disease monitoring, and specialized imaging workflows.

The industry value chain begins with specialized detector materials, scintillation components, photodetectors, semiconductor electronics, collimators, mechanical assemblies, batteries, displays, and imaging software. Manufacturers integrate these inputs into detector heads, acquisition electronics, mobile platforms, control systems, and image-processing architectures before undertaking calibration, quality assurance, and regulatory testing.

Mobile Gamma Cameras Market: Growth Drivers & Challenges

Growth Drivers

• Growing Adoption of Nuclear Medicine for Cancer Diagnosis: Increasing use of nuclear medicine in oncology is supporting demand for gamma-camera systems, including mobile configurations that can provide greater flexibility within healthcare facilities. Nuclear medicine enables functional and molecular imaging, making it valuable for detecting disease activity, assessing treatment response, and supporting cancer staging. India's Atomic Energy Regulatory Board explains that gamma cameras detect radiation emitted by radiopharmaceuticals and are used for imaging in cancer, cardiac, endocrine, and neurological conditions.
• Increasing Demand for Flexible and Patient-Centric Imaging: The second growth driver is the healthcare industry's increasing emphasis on flexible diagnostic workflows and patient-centric imaging. Conventional fixed nuclear medicine systems require dedicated rooms and patient movement to centralized imaging departments. Mobile gamma cameras can provide greater operational flexibility by allowing imaging equipment to be moved within suitable clinical environments. This capability can be valuable when patients have limited mobility, when specialized imaging is required near treatment areas, or when healthcare organizations seek to improve utilization of diagnostic equipment.

Challenges

• High System Cost and Technical Complexity: Mobile gamma cameras require sophisticated detectors, collimators, electronics, imaging software, mechanical systems, and radiation-shielding considerations. Integrating these elements into a mobile platform while maintaining image quality and operational reliability creates substantial engineering and manufacturing complexity. Healthcare providers must also evaluate lifecycle costs, maintenance requirements, calibration, and staff training before deployment. These factors can limit adoption among smaller healthcare facilities and organizations operating under constrained capital budgets.
• Radiation-Safety and Regulatory Requirements: The use of radioactive materials and gamma-radiation detection creates stringent requirements for facility operation, equipment quality assurance, personnel protection, and regulatory compliance. The Atomic Energy Regulatory Board requires nuclear medicine facilities to meet applicable regulatory requirements and obtain regulatory consent through its licensing framework. Such requirements can lengthen procurement and deployment processes and increase compliance costs.